Intermolecular Inc (NASDAQ:IMI) was the recipient of a significant drop in short interest in July. As of July 31st, there was short interest totalling 10,300 shares, a drop of 7.2% from the June 30th total of 11,100 shares. Based on an average daily volume of 230,700 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the company’s stock are sold short.
A number of research analysts have weighed in on the company. Lake Street Capital downgraded Intermolecular from a “buy” rating to a “hold” rating in a research note on Monday, May 6th. ValuEngine upgraded Intermolecular from a “hold” rating to a “buy” rating in a research note on Thursday, August 1st.
A number of hedge funds have recently bought and sold shares of IMI. B. Riley Financial Inc. acquired a new position in Intermolecular in the first quarter valued at about $2,797,000. FNY Investment Advisers LLC bought a new stake in shares of Intermolecular in the second quarter worth about $316,000. Gabelli Funds LLC bought a new stake in shares of Intermolecular in the second quarter worth about $2,421,000. GABELLI & Co INVESTMENT ADVISERS INC. bought a new stake in shares of Intermolecular in the second quarter worth about $1,656,000. Finally, Water Island Capital LLC bought a new stake in shares of Intermolecular in the second quarter worth about $1,167,000. Hedge funds and other institutional investors own 53.83% of the company’s stock.
IMI stock traded up $0.01 during mid-day trading on Friday, reaching $1.18. The company had a trading volume of 110,200 shares, compared to its average volume of 294,424. The company has a quick ratio of 5.84, a current ratio of 4.74 and a debt-to-equity ratio of 0.43. The stock has a 50 day simple moving average of $1.17 and a two-hundred day simple moving average of $1.13. Intermolecular has a 52 week low of $0.88 and a 52 week high of $1.42.
Intermolecular (NASDAQ:IMI) last posted its quarterly earnings results on Thursday, August 8th. The semiconductor company reported ($0.11) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.03) by ($0.08). The company had revenue of $4.62 million during the quarter. Intermolecular had a negative net margin of 42.74% and a negative return on equity of 33.13%.
Intermolecular, Inc engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods.
Further Reading: How is a price target determined?
Receive News & Ratings for Intermolecular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular and related companies with MarketBeat.com's FREE daily email newsletter.